Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-008047
Filing Date
2021-04-06
Accepted
2021-04-06 06:10:36
Documents
57
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1008361
2 ex31-1.htm EX-31.1 12238
3 ex32-1.htm EX-32.1 5557
  Complete submission text file 0001493152-21-008047.txt   3214385

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE sign-20201231.xml EX-101.INS 388511
5 XBRL SCHEMA FILE sign-20201231.xsd EX-101.SCH 29781
6 XBRL CALCULATION FILE sign-20201231_cal.xml EX-101.CAL 40599
7 XBRL DEFINITION FILE sign-20201231_def.xml EX-101.DEF 98914
8 XBRL LABEL FILE sign-20201231_lab.xml EX-101.LAB 206044
9 XBRL PRESENTATION FILE sign-20201231_pre.xml EX-101.PRE 176724
Mailing Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212
Business Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212 619-368-2000
Sigyn Therapeutics, Inc. (Filer) CIK: 0001642159 (see all company filings)

EIN.: 472573116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55575 | Film No.: 21808060
SIC: 3841 Surgical & Medical Instruments & Apparatus